Atlas Trials

CytoDyn, Inc.

24 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch CytoDyn, Inc.

RecordFirmDate
The Phase-2 CCR5-targeting Leronlimab With Oral Chemotherapy and VEGF-inhibitor Enriched Regimen Trial (CLOVER) (NCT06699836)CytoDyn, Inc.2025-06-16
Leronlimab in Combination With Regorafenib in Patients With CCR5+, Metastatic Colorectal Cancer (NCT05730673)CytoDyn, Inc.2022-09-20
Double Blind, Placebo Controlled Study of Safety and Efficacy of Leronlimab in Patients With "Long" COVID-19 (NCT04678830)CytoDyn, Inc.2021-03-01
Leronlimab (PRO 140) in Patients With Nonalcoholic Steatohepatitis (NCT04521114)CytoDyn, Inc.2020-12-01
Basket Study of Leronlimab (PRO 140) in Patients With CCR5+ Locally Advanced or Metastatic Solid Tumors (NCT04504942)CytoDyn, Inc.2020-05-01
Evaluate the Efficacy & Safety of Leronlimab in Patients With Severe or Critical COVID-19 (NCT04347239)CytoDyn, Inc.2020-04-16
Leronlimab (PRO 140) Combined With Carboplatin in Patients With Cytokine Chemokine Receptor 5 Positive (CCR5+) mTNBC (NCT03838367)CytoDyn, Inc.2019-04-22
PRO 140 in Treatment-Experienced HIV-1 Subjects (NCT03902522)CytoDyn, Inc.2018-06-25

Track CytoDyn, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.